Overview

Study in Intensive Care Patients Regarding the Effect of Inhaled AP-301 After Primary Graft Dysfunction After Lung Transplantation

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effect of orally inhaled AP-301 on primary graft dysfunction after lung transplantation.
Phase:
Phase 2
Details
Lead Sponsor:
Apeptico Forschung und Entwicklung GmbH
Treatments:
Pharmaceutical Solutions